Correlation between myocardial malate/aspartate shuttle activity and EAAT1 protein expression in hyper- and hypothyroidism

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Ralphe, J Carter ^a,b   Bedell, Kurt ^a   Segar, Jeffrey L ^a   Scholz, Thomas D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Myocardial hypertrophy; Thyroid hormone

Indexed keywords

ARALAR 1; ASPARTATE GLUTAMATE TRANSPORTER; ASPARTIC ACID; CARRIER PROTEIN; ERIODICTYOL 7 O GLUCOSIDE; EXCITATORY AMINO ACID TRANSPORTER; IMMUNOGLOBULIN G ANTIBODY; LIOTHYRONINE; MALIC ACID; MESSENGER RNA; PROPYLTHIOURACIL; PROTEIN HYDROLYSATE; RNA 18S; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HYPERTHYROIDISM; HYPOTHYROIDISM; MALATE ASPARTATE CYCLE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPECTROPHOTOMETRY; STEADY STATE; UPREGULATION;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASPARTIC ACID; CARDIOMEGALY; EXCITATORY AMINO ACID TRANSPORTER 1; GENE EXPRESSION; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOBLOTTING; MALATES; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SYMPORTERS; TRIIODOTHYRONINE;

EID: 18044364838     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00991.2004     Document Type: Article

References (30)

1. Allard MF, Schonekess BO, Henning SL, English DR, and Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol Heart Circ Physiol 267: H742-H750, 1994.
2. Bonham MJ and Danielpour D. Improved purification and yields of RNA by RNeasy. Biotechniques 21: 57-60, 1996.
3. Dawson AG. Oxidation of cytosolic NADH formed during aerobic metabolism in mammalian cells. Trends Biochem Sci 4: 171-176, 1979.
4. Del Arco A, Agudo M, and Satrustegui J. Characterization of a second member of the subfamily of calcium-binding mitochondrial carriers expressed in human non-excitable tissues. Biochem J 345: 725-732, 2000.
5. Del Arco A, Morcillo J, Martinez-Morales JR, Galian C, Martos V, Bovolenta P, and Satrustegui J. Expression of the aspartate/glutamate mitochondrial carriers aralar1 and citrin during development and in adult rat tissues. Eur J Biochem 269: 3313-3320, 2002.
6. Desai-Yajnik V and Samuels HH. The NF-κB and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Mol Cell Biol 13: 5057-5069, 1993.
7. Eynan M, Knubuvetz T, Mein U, Navon G, Gerstenblith G, Bromberg Z, Hasin Y, and Horowitz M. Heat acclimation-induced elevated glycogen, glycolysis, and low thyroxine improve heart ischemic tolerance. J Appl Physiol 93: 2095-2104, 2002.
8. Goglia F, Moreno M, and Lanni A. Action of thyroid hormones at the cellular level: the mitochondrial target. FEBS Lett 452: 115-120, 1999.
9. Gomberg-Maitland M and Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J 135: 187-196, 1998.
10. Hagiwara T, Tanaka K, Takai S, Maeno-Hikichi Y, Mukainaka Y, and Wada K. Genomic organization, promoter analysis, and chromosomal localization of the gene for the mouse glial high-affinity glutamate transporter Slcla3. Genomics 33: 508-515, 1996.
11. Hollenberg AN, Monden T, and Wondisford FE. Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon their distinct amino termini. J Biol Chem 270: 14274-14280, 1995.
12. Hood DA, Takahashi M, Connor MK, and Freyssenet D. Assembly of the cellular powerhouse: current issues in muscle mitochondrial biogenesis. Exerc Sport Sci Rev 28: 68-73, 2000.
13. Kim MK, Lee JS, and Chung JH. In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation. Proc Natl Acad Sci USA 96: 10092-10097, 1999.
14. Klein I. Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol. Endocrinology 123: 203-210, 1988.
15. Kunz WS and Davis EJ. Control of reversible intracellular transfer of reducing potential. Arch Biochem Biophys 284: 40-46, 1991.
16. LaNoue KF and Tischler ME. Electrogenic characteristics of the mitochondrial glutamate-aspartate antiporter. J Biol Chem 249: 7522-7528, 1974.
17. McKee E, Grier B, Thompson G, and McCourt J. Isolation and incubation conditions to study heart mitochondrial protein synthesis. Am J Physiol Endocrinol Metab 258: E492-E502, 1990.
18. Mutvei A, Husman B, Andersson G, and Nelson BD. Thyroid hormone and not growth hormone is the principle regulator of mammalian mitochondrial biogenesis. Acta Endocrinol 121: 223-228, 1989.
19. Mutvei A, Kuzela S, and Nelson BD. Control of mitochondrial transcription by thyroid hormone. Eur J Biochem 180: 235-240, 1989.
20. 2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20: 5060-5069, 2001.
21. Pantos C, Malliopoulou V, Mourouzis I, Sfakianoudis K, Tzeis S, Doumba P, Xinaris C, Cokkinos AD, Carageorgiou H, Varonos DD, and Cokkinos DV. Propylthiouracil-induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischaemia-reperfusion. J Endocrinol 178: 427-435, 2003.
22. Pantos C, Malliopoulou V, Varonos DD, and Cokkinos DV. Thyroid hormone and phenotypes of cardioprotection. Basic Res Cardiol 99: 101-120, 2004.
23. Ralphe J, Segar J, Schutte E, and Scholz T. Expression and function of brain EAAT1 in cardiac mitochondria. J Mol Cell Cardiol, 2004.
24. Scholz T, TenEyck C, and Schutte B. Developmental up-regulation of a housekeeping gene: glyceraldenyde-3-phosphate dehydrogenase (GAPDH). J Investig Med 45: 295A, 1997.
25. Scholz TD and Koppenhafer SL. Reducing equivalent shuttles in developing myocardium: enhanced capacity in the newborn heart. Pediatr Res 38: 221-227, 1995.
26. Scholz TD, Koppenhafer SL, tenEyck CJ, and Schutte BC. Ontogeny of malate-aspartate shuttle capacity and gene expression in cardiac mitochondria. Am J Physiol Cell Physiol 274: C780-C788, 1998.
27. Scholz TD, Laughlin MR, Balaban RS, Kupriyanov VV, and Heineman FW. Effect of substrate on mitochondrial NADH, cytosolic redox state, and phosphorylated compounds in isolated hearts. Am J Physiol Heart Circ Physiol 268: H82-H91, 1995.
28. Scholz TD, TenEyck CJ, and Schutte BC. Thyroid hormone regulation of the NADH shuttles in liver and cardiac mitochondria. J Mol Cell Cardiol 32: 1-10, 2000.
29. Sheehan TE, Kumar PA, and Hood DA. Tissue-specific regulation of cytochrome-c oxidase subunit expression by thyroid hormone. Am J Physiol Endocrinol Metab 286: E968-E974, 2004.
30. +-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89: 10955-10959, 1992.